MetaCap

Ascentage Pharma Group International American Depository Shares (AAPG) vs City Therapeutics (CTY)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Ascentage Pharma Group International American Depository Shares is the larger company by market cap ($1.12 billion vs $1.03 billion), about 1.1 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

AAPG-22.12%CTY-13.75%
+8%-10%-28%
Oct 16, 20261 yearNov 20, 2026
AAPG-22.12%CTY-13.75%
+2%-11%-23%
Oct 12, 20265 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

AAPG versus CTY key metrics
MetricAAPGCTY
Share price$11.97$19.32
Market cap$1.12B$1.03B
1-day change-3.78%+5.29%
YTD return-54.38%—
1-year return-60.93%—
EPS (TTM)$-2.26$-2.53
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)$134.35M—
Net income (latest FY)$-55.54M—
Gross margin97.03%—
Net margin-41.34%—
52-week high$33.09$23.88
52-week low$11.97$15.81
Distance from 52-week high-63.83%-19.10%
Analyst consensusstrong_buystrong_buy
Avg. price target upside+271.76%+93.22%
Average volume6.97K328.87K
Shares outstanding93.33M53.39M
Employees82875
SectorHealth CareHealth Care
IndustryBiotechnology: Pharmaceutical PreparationsBiotechnology: Pharmaceutical Preparations

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

About Ascentage Pharma Group International American Depository Shares

AAPG stock →

Ascentage Pharma Group International, a clinical-stage biotechnology company, develops therapies for cancers, chronic hepatitis B virus (HBV), and age-related diseases in Mainland China. The company's primary product candidate is HQP1351, a BCR-ABL inhibitor targeting BCR-ABL1 mutants, including those with the T315I mutation.

Health Care · Biotechnology: Pharmaceutical Preparations · 828 employees

About City Therapeutics

CTY stock →

City Therapeutics, Inc. operates as a biopharmaceutical company focused on developing RNA interference (RNAi)-based medicines by engineering RNAi trigger molecules.

Health Care · Biotechnology: Pharmaceutical Preparations · 75 employees

AAPG vs CTY FAQ

Which is bigger, Ascentage Pharma Group International American Depository Shares or City Therapeutics?

Ascentage Pharma Group International American Depository Shares (AAPG) is larger, with a market capitalization of $1.12B compared with $1.03B for City Therapeutics (CTY).

Are Ascentage Pharma Group International American Depository Shares and City Therapeutics in the same industry?

Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.

More comparisons